Unmasking Crohn’s Disease: Anti-glycan antibodies (ACCA, ALCA, AMCA) may improve diagnostic accuracy while providing prognostic value, especially in ASCA-seronegative patients

Anti-glycan antibodies are found in patients with Crohn’s disease and finding more than one antibody indicates faster progression of the disease. This poster compares the results of these anti-glycan antibodies with a conventional IBD antibody marker.